Kuvatris Therapeutics Inc (PXMD) Stock Price & News

All values in USD	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	116.93K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	771.00K
Operating expense	-	-	-	887.94K
Total operating expenses	-	-	-	887.94K
Operating income	-	-	-	-887.94K
Other non operating income	-	-	-	11.30K
EBT including unusual items	-	-	-	-876.64K
EBT excluding unusual items	-	-	-	-876.64K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-	-	-	-876.64K
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance